(19)
(11) EP 4 355 751 A1

(12)

(43) Date of publication:
24.04.2024 Bulletin 2024/17

(21) Application number: 22740705.3

(22) Date of filing: 13.06.2022
(51) International Patent Classification (IPC): 
C07D 519/00(2006.01)
A61K 31/519(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 519/00; A61P 35/00
(86) International application number:
PCT/US2022/033305
(87) International publication number:
WO 2022/266015 (22.12.2022 Gazette 2022/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 14.06.2021 US 202163210474 P
17.12.2021 US 202163291320 P
23.02.2022 US 202263313132 P

(71) Applicant: Kumquat Biosciences Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • LI, Liansheng
    San Diego, CA 92121 (US)
  • ZHU, Xiuwen
    San Diego, CA 92121 (US)
  • REN, Pingda
    San Diego, CA 92121 (US)
  • LIU, Yi
    San Diego, CA 92121 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) FUSED HETEROARYL COMPOUNDS USEFUL AS ANTICANCER AGENTS